FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312877617> ?p ?o ?g. }

• W2312877617 endingPage "1872" @default.
• W2312877617 startingPage "1860" @default.
• W2312877617 abstract "Prostate cancer is a major cause of male cancer death. In vitro and in vivo data support a role for 1 alpha,25 Dihydroxyvitamin D(3) (1 alpha,25(OH)(2)D(3)) in regulating the growth and differentiation of the normal prostate gland yet prostate cancer cells appear significantly less sensitive to this action. Vitamin D(3) receptor (VDR) content or mutational status do not correlate clearly with the antiproliferative effects of 1 alpha,25(OH)(2)D(3) and therefore it is unclear why prostate cancer cell lines are significantly less sensitive to this action. We hypothesized that the antiproliferative responses of prostate cancer cells to 1 alpha,25(OH)(2)D(3) are suppressed by a process involving histone deacetylation. Sodium butyrate (NaB) and trichostatin A (TSA) are inhibitors of histone deacetylase (HDAC) activity. Low doses of NaB or TSA (300 microM and 15 nM respectively), which alone were relatively inactive, synergized with 1 alpha,25(OH)(2)D(3) in liquid and semi-solid agar to inhibit the growth of LNCaP, PC-3 and DU-145 prostate cancer cells. Still greater synergy was observed between vitamin D(3) hexafluoride analogs and either NaB or TSA. The mechanism appeared to involve neither the cyclin-dependent kinase inhibitor, p21((waf1/cip1)) nor cell cycle arrest, but rather induction of apoptosis. These data suggest that cells dysregulate the normal pro-apoptotic signals of 1 alpha,25(OH)(2)D(3) during prostate cancer development by a mechanism involving histone deacetylation. Combination therapy with potent vitamin D(3) analogs and clinically approved HDAC inhibitors may overcome this lesion and improve the treatment of both androgen-dependent and independent prostate cancer." @default.
• W2312877617 created "2016-06-24" @default.
• W2312877617 creator A5020203557 @default.
• W2312877617 creator A5022027469 @default.
• W2312877617 creator A5034479183 @default.
• W2312877617 creator A5037009937 @default.
• W2312877617 creator A5047413043 @default.
• W2312877617 creator A5060760341 @default.
• W2312877617 creator A5065194764 @default.
• W2312877617 creator A5069488951 @default.
• W2312877617 creator A5084051050 @default.
• W2312877617 date "2001-04-05" @default.
• W2312877617 modified "2023-10-14" @default.
• W2312877617 title "Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A" @default.
• W2312877617 cites W1486948598 @default.
• W2312877617 cites W1488591768 @default.
• W2312877617 cites W1511815964 @default.
• W2312877617 cites W1550565578 @default.
• W2312877617 cites W1563624749 @default.
• W2312877617 cites W1593089530 @default.
• W2312877617 cites W1613446635 @default.
• W2312877617 cites W1828113237 @default.
• W2312877617 cites W1866128922 @default.
• W2312877617 cites W1973392312 @default.
• W2312877617 cites W1984041392 @default.
• W2312877617 cites W1986527803 @default.
• W2312877617 cites W1996203783 @default.
• W2312877617 cites W2003834271 @default.
• W2312877617 cites W2003944589 @default.
• W2312877617 cites W2004103680 @default.
• W2312877617 cites W2013850508 @default.
• W2312877617 cites W2017228377 @default.
• W2312877617 cites W2022625426 @default.
• W2312877617 cites W2025407891 @default.
• W2312877617 cites W2026237709 @default.
• W2312877617 cites W2030735294 @default.
• W2312877617 cites W2039457793 @default.
• W2312877617 cites W2051271305 @default.
• W2312877617 cites W2060128629 @default.
• W2312877617 cites W2061722441 @default.
• W2312877617 cites W2063667483 @default.
• W2312877617 cites W2064148273 @default.
• W2312877617 cites W2068776651 @default.
• W2312877617 cites W2071429904 @default.
• W2312877617 cites W2073026049 @default.
• W2312877617 cites W2077498188 @default.
• W2312877617 cites W2077626320 @default.
• W2312877617 cites W2077984631 @default.
• W2312877617 cites W2085732078 @default.
• W2312877617 cites W2091089282 @default.
• W2312877617 cites W2099691945 @default.
• W2312877617 cites W2129750923 @default.
• W2312877617 cites W2138768698 @default.
• W2312877617 cites W2155774692 @default.
• W2312877617 cites W2161103103 @default.
• W2312877617 cites W2162741492 @default.
• W2312877617 cites W2165436746 @default.
• W2312877617 cites W2166560458 @default.
• W2312877617 cites W2406617892 @default.
• W2312877617 cites W2416433152 @default.
• W2312877617 cites W4205101271 @default.
• W2312877617 cites W4256691746 @default.
• W2312877617 doi "https://doi.org/10.1038/sj.onc.1204269" @default.
• W2312877617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11313934" @default.
• W2312877617 hasPublicationYear "2001" @default.
• W2312877617 type Work @default.
• W2312877617 sameAs 2312877617 @default.
• W2312877617 citedByCount "111" @default.
• W2312877617 countsByYear W23128776172012 @default.
• W2312877617 countsByYear W23128776172013 @default.
• W2312877617 countsByYear W23128776172014 @default.
• W2312877617 countsByYear W23128776172015 @default.
• W2312877617 countsByYear W23128776172016 @default.
• W2312877617 countsByYear W23128776172017 @default.
• W2312877617 countsByYear W23128776172018 @default.
• W2312877617 countsByYear W23128776172019 @default.
• W2312877617 countsByYear W23128776172020 @default.
• W2312877617 countsByYear W23128776172022 @default.
• W2312877617 countsByYear W23128776172023 @default.
• W2312877617 crossrefType "journal-article" @default.
• W2312877617 hasAuthorship W2312877617A5020203557 @default.
• W2312877617 hasAuthorship W2312877617A5022027469 @default.
• W2312877617 hasAuthorship W2312877617A5034479183 @default.
• W2312877617 hasAuthorship W2312877617A5037009937 @default.
• W2312877617 hasAuthorship W2312877617A5047413043 @default.
• W2312877617 hasAuthorship W2312877617A5060760341 @default.
• W2312877617 hasAuthorship W2312877617A5065194764 @default.
• W2312877617 hasAuthorship W2312877617A5069488951 @default.
• W2312877617 hasAuthorship W2312877617A5084051050 @default.
• W2312877617 hasBestOaLocation W23128776171 @default.
• W2312877617 hasConcept C104317684 @default.
• W2312877617 hasConcept C121608353 @default.
• W2312877617 hasConcept C126322002 @default.
• W2312877617 hasConcept C134018914 @default.
• W2312877617 hasConcept C190283241 @default.
• W2312877617 hasConcept C2777865847 @default.
• W2312877617 hasConcept C2778305200 @default.
• W2312877617 hasConcept C2778942008 @default.

• next